玻璃体切除联合玻璃体后脱离后玻璃体腔注射曲安奈德治疗增殖性糖尿病视网膜病变的长期结局
回顾性分析189眼(152例)因严重增殖性糖尿病视网膜病变行玻璃体切除术的病例,其中118眼在玻璃体后脱离后接受玻璃体腔注射曲安奈德(40 mg/mL,0.1 mL),71眼未接受。随访至少12个月,注射组最佳矫正视力显著改善且眼压控制良好,术后早期复发性玻璃体出血发生率显著低于未注射组(1.7% vs 9.9%,p=0.028)。
要点
- 玻璃体后脱离后玻璃体腔注射曲安奈德有助于术中增殖膜剥离和止血。
- 注射组术后早期复发性玻璃体出血发生率为1.7%,显著低于未注射组的9.9%(p=0.028)。
- 注射组最佳矫正视力显著改善,随访期间眼压控制良好。
核心结论
- 玻璃体后脱离后在玻璃体切除术中行玻璃体腔注射曲安奈德可有效改善严重增殖性糖尿病视网膜病变患者的最终视力结局并预防术后并发症。
研究设计与样本
- 回顾性分析189眼(152例)因严重增殖性糖尿病视网膜病变行玻璃体切除术的病例,其中118眼接受玻璃体腔注射曲安奈德(PPV+IVTA组),71眼未接受(PPV组)。
- 玻璃体后脱离后、大部分玻璃体和增殖膜被清除时,向PPV+IVTA组玻璃体腔注射0.1 mL曲安奈德(40 mg/mL)。
- 所有患者随访至少12个月,记录并比较两组视力结局和术后并发症。
主要发现
- 玻璃体腔注射曲安奈德有助于玻璃体切除术中增殖膜剥离和止血。
- PPV+IVTA组最佳矫正视力显著改善,随访期间眼压控制良好。
- PPV+IVTA组术后早期复发性玻璃体出血发生率为1.7%,PPV组为9.9%(p=0.028)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To evaluate the long-term outcomes of intravitreal triamcinolone acetonide (TA) administration after posterior vitreous detachment (PVD) during pars plana vitrectomy (PPV) for patients with proliferative diabetic retinopathy (PDR). METHODS: A total of 189 eyes (152 patients) who underwent PPV for severe PDR were reviewed. Intravitreal injection of TA (IVTA) was administered during PPV in 118 eyes (PPV+IVTA group), and 71 eyes did not receive IVTA (PPV group). Immediately after PVD, when most of the vitreous and proliferative membranes were removed, 0.1 mL TA (40 mg/mL) was injected into the vitreous cavity in the PPV+IVTA group. All patients were followed-up for least 12 months. Visual outcomes and postoperative complications were recorded and compared between the two groups. RESULTS: IVTA was helpful for proliferative membrane peeling and haemostasis during PPV. In the PPV+IVTA group, best-corrected visual acuity had significantly improved and the intraocular pressure was controlled well during the follow-up. The incidence of early recurrent vitreous haemorrhage after PPV was significantly lower in the PPV+IVTA group (1.7%) than in the PPV group (9.9%) (p=0.028). CONCLUSION: The administration of IVTA after PVD during PPV can effectively improve the final visual outcomes and prevent postoperative complications in patients with severe PDR.
引用
- Liao M, Huang Y, Wang J, et al. Long-term outcomes of administration of intravitreal triamcinolone acetonide after posterior vitreous detachment during pars plana vitrectomy for proliferative diabetic retinopathy. Br J Ophthalmol. 2021. PMID: 34844917. doi:10.1136/bjophthalmol-2021-320332
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。